Biotech Showcase 2012
January 11, 2012 at 10:00 a.m.

Parc 55 Wyndham Hotel, San Francisco

view Biotech Showcase Web site

10th Annual Bio Investor Forum
October 26, 2011 at 9:30 a.m.

Palace Hotel in San Francisco

Subject: Company overview and update on anthim development progress

view Bio Investor Forum Web site

AAPS National Biotechnology Conference

Immunogenicity Assessment of Humanized Deimmunized Therapeutic Monoclonal Antibody ETI-204 (Anthim^®) in a Phase I Clinical Study with a Validated Electrochemiluminescence Immunoassay

click to view pdf

Bacillus ACT 2009

ETI-204 Anti-Toxin Monoclonal Antibody Treatment of Active Anthrax Disease in Rabbits

click to view pdf

ICAAC 2008 Anthim
ETI-204 Provides a Dramatic Improvement in Survival at the Onset of Active Anthrax Disease and is Well Tolerated in Nonhuman Primates

click to view pdf